ArticleBMC cancer2023

Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre.

David K Lau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.